Back to search
Advanced Breast Cancer (Parts 1 and 2)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Breast Cancer (Parts 1 and 2) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Breast Cancer (Parts 1 and 2) trials you may qualify forThe purpose of this first-in-human (FIH) study is to evaluate the safety, tolerability, Pharmacokinetics (PK), and preliminary clinical activity of M7437 in par…
This is a Phase I/II, multi-site, open-label, two-part study designed to evaluate the efficacy, safety, optimized dose and contribution of components of BNT323…
The purpose of this study is to assess the safety and efficacy of alpelisib plus fulvestrant in men and postmenopausal women with hormone receptor (HR) positive…
The purpose of this two part multicenter, randomized, double-blind, placebo-controlled, Phase III study is to evaluate the efficacy and safety of alpelisib comp…